Metraipolis › archive › dc_02fcdbca7f5c

[A Case of EGFR-mutant Lung Adenocarcinoma with Secondary SCLC Transformation and ALK Fusion after Osimertinib Treatment] — Europe PMC PMID:42290055

Source: Europe PMC (chi)
Original: https://europepmc.org/article/MED/42290055
DOI: 10.3779/j.issn.1009-3419.2026.101.09
License (as archived): solo-consultazione
Archived: 2026-11-03T13:34:43.840Z
SHA-256 of the archived text: e06163a55c5daf0bf1b370770c51b1accd1384cfd499e1b682e7bbcc57a7a498
Stable URL of this page: https://metraipolis.com/documento/dc_02fcdbca7f5c

How to cite

[A Case of EGFR-mutant Lung Adenocarcinoma with Secondary SCLC Transformation and ALK Fusion after Osimertinib Treatment] — Europe PMC PMID:42290055 — Europe PMC (chi), https://europepmc.org/article/MED/42290055 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_02fcdbca7f5c (Metraipolis archive dc_02fcdbca7f5c, sha256 e06163a55c5daf0bf1b370770c51b1accd1384cfd499e1b682e7bbcc57a7a498)

BibTeX

@misc{dc02fcdbca7f5c,
  title = {[A Case of EGFR-mutant Lung Adenocarcinoma with Secondary SCLC Transformation and ALK Fusion after Osimertinib Treatment] — Europe PMC PMID:42290055},
  howpublished = {Europe PMC (chi)},
  url = {https://europepmc.org/article/MED/42290055},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_02fcdbca7f5c; sha256 e06163a55c5daf0bf1b370770c51b1accd1384cfd499e1b682e7bbcc57a7a498},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42290055. Agents can read the archived copy with the MCP tool read_document.